Oncobiology Symposium
ISSN: 2966-4438
Papers (15)
-
OXYRESVERATROL INDUCES APOPTOSIS VIA CASPASE-3 IN MDA-MB-231 BREAST CANCER CELLS
Vol 1, 2020 -131279 -
CRUDE EXTRACT OF FRUITS OF BONNETIA sp. ALTERS CELL CYCLE OF BREAST CANCER CELLS
Vol 1, 2020 -131352 -
COTREATMENT OF CURCUMIN AND MELPHALAN INDUCES CELL DEATH IN MDA-MB-231 BREAST CANCER CELLS
Vol 3, 2022 -154993 -
CYTOTOXIC AND ANTIOXIDANT POTENTIAL FROM LEAVE EXTRACT OF Begonia luxurians Scheidw. AGAINST BREAST CANCER CELL LINES
Vol 3, 2022 -154997 -
IDENTIFICATION OF METABOLITES IN BREAST CANCER CELLS AFTER PIPERINE TREATMENT
Vol 3, 2022 -155231 -
SCREENING OF BIOACTIVE COMPOUNDS FROM FOODS IN A MURINE MODEL OF BREAST CANCER LINE 67NR
Vol 3, 2022 -155241 -
PHYTOCHEMICAL AND CYTOTOXIC STUDIES BY HYDROALCOHOLIC EXTRACT OF FRUITS OF Bonnetia stricta ON MDA-MB-231 CELLS
-166611 -
EVALUATION OF CYTOTOXICITY OF RESVERATROL ANALOGUES ISORHAPONTIGENIN, DESOXYRHAPONTIGENIN AND CHEMOTERAPIC DRUGS IN AGGRESSIVE AND NON-AGGRESSIVE CANCER CELLS
-166894 -
SYNERGIC EFFECT BETWEEN OXYRESVERATROL AND DOXORUBICIN IN A MURINE BREAST CANCER MODEL
-167049 -
IN SILICO ANALYSIS OF IMPACT OF RESVERATROL AND APE1 INHIBITION GENE SIGNATURES EXPRESSION ON BREAST CANCER PROGRESSION
-315398 -
EFFECT OF SIMULATED MICROGRAVITY BY CLINOSTAT 1D ON TUMORAL AND NON-TUMORAL MAMMARY CELLS
VOL XVIII, Ano 2024 -315159 -
Effect of Hibiscus sabdariffa L. Aqueous Extract in Aggressive Breast Cancer Cell MDA-MB-231
VOL XVIII, Ano 2024 -315130 -
CYTOTOXIC EFFECTS OF CURCUMIN WITH DOXORUBICIN IN MURINE BREAST CANCER CELLS
VOL XVIII, Ano 2024 -314885 -
COTREATMENT OF RESVERATROL ANALOGUE ISORHAPONTIGENIN WITH EITHER DOXORUBICIN OR MELPHALAN IN MCF-7 BREAST CANCER CELLS
VOL XVIII, Ano 2024 -314867 -
CYTOTOXIC EFFECT OF OXYRESVERATROL ON MURINE BREAST CANCER CELLS UNDER NORMOXIA AND HYPOXIA CONDITIONS
VOL XVIII, Ano 2024 -314826
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
